David Shang
Stock Analyst at Jefferies
(0.70)
# 3,983
Out of 4,592 analysts
14
Total ratings
23.1%
Success rate
-8.2%
Average return
Main Sectors:
Stocks Rated by David Shang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1875 BioDlink International Company Limited | Maintained: Buy | $4.40 | $3.21 | +37.07% | 1 | Jun 8, 2026 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Maintained: Buy | $55.00 | $37.72 | +45.81% | 1 | Mar 31, 2026 | |
| HKG: 9860 Adicon Holdings Limited | Maintained: Buy | $7.00 | $3.30 | +112.12% | 1 | Mar 31, 2026 | |
| HKG: 1066 Shandong Weigao Group Medical Polymer Company Limited | Maintained: Buy | $5.20 → $5.50 | $3.36 | +63.69% | 2 | Mar 30, 2026 | |
| HKG: 1789 AK Medical Holdings Limited | Maintained: Buy | $5.50 → $7.50 | $5.51 | +36.12% | 2 | Mar 30, 2026 | |
| HKG: 2252 Shanghai MicroPort MedBot (Group) Co., Ltd. | Maintained: Buy | $35.00 → $40.00 | $20.82 | +92.12% | 4 | Mar 30, 2026 | |
| HKG: 3933 The United Laboratories International Holdings Limited | Maintained: Buy | $17.00 → $20.00 | $8.92 | +124.22% | 2 | Sep 5, 2025 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Maintained: Hold | $4.60 | $8.58 | n/a | 1 | Jan 22, 2025 |
BioDlink International Company Limited
Jun 8, 2026
Maintained: Buy
Price Target: $4.40
Current: $3.21
Upside: +37.07%
Hangzhou Tigermed Consulting Co., Ltd
Mar 31, 2026
Maintained: Buy
Price Target: $55.00
Current: $37.72
Upside: +45.81%
Adicon Holdings Limited
Mar 31, 2026
Maintained: Buy
Price Target: $7.00
Current: $3.30
Upside: +112.12%
Shandong Weigao Group Medical Polymer Company Limited
Mar 30, 2026
Maintained: Buy
Price Target: $5.20 → $5.50
Current: $3.36
Upside: +63.69%
AK Medical Holdings Limited
Mar 30, 2026
Maintained: Buy
Price Target: $5.50 → $7.50
Current: $5.51
Upside: +36.12%
Shanghai MicroPort MedBot (Group) Co., Ltd.
Mar 30, 2026
Maintained: Buy
Price Target: $35.00 → $40.00
Current: $20.82
Upside: +92.12%
The United Laboratories International Holdings Limited
Sep 5, 2025
Maintained: Buy
Price Target: $17.00 → $20.00
Current: $8.92
Upside: +124.22%
CSPC Pharmaceutical Group Limited
Jan 22, 2025
Maintained: Hold
Price Target: $4.60
Current: $8.58
Upside: n/a